Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-41.59% · OPTIONAL · VALID
Syndax Pharmaceuticals Inc. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-41.59% · OPTIONAL · VALID
Yoy · gp.fundamentals.revenue
91.76% · CORE · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.inventory_revenue_ratio
45.56% · OPTIONAL · NOT_ENOUGH_HISTORY
Level · gp.fundamentals.operating_margin
-54.95% · CORE · VALID
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
93.47% · OPTIONAL · VALID
Level · gp.fundamentals.sbc_revenue_ratio
19.25% · OPTIONAL · VALID
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.